Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-20 · accession 0001104659-24-074012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-21 | 2024-06-20 | OBIO | Aryeh Jason | Dir | A - Grant | $0.00 | +5,376 | 68.4K | +9% | $0 |
| D | 2024-06-21 | 2024-06-20 | OBIO | Aryeh Jason | Dir | A - Grant | $0.00 | +17.1K | 17.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2024-06-20 | A | A | 5,376 | $0.00 | 68,360 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 20, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-20 | A | A | 17,068 | $0.00 | 17,068 | D | $7.44 · 2025-06-20 to 2034-06-20 | 17,068 Common Stock |